ProfileGDS4459 / ENSG00000196967
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 7% 28% 31% 22% 57% 36% 24% 40% 31% 33% 45% 32% 29% 22% 32% 7% 31% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.687
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.7228
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.5731
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.5822
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.6957
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.8736
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.2224
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.9640
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.5831
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.7333
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.145
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.5832
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.5829
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.522
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.5832
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.747
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.7531